HomeIGMS • NASDAQ
add
IGM Biosciences Inc
Previous close
$1.38
Day range
$1.31 - $1.40
Year range
$0.92 - $22.50
Market cap
78.90M USD
Avg Volume
180.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 412.00K | -36.71% |
Operating expense | 1.76M | -84.69% |
Net income | -36.65M | 39.62% |
Net profit margin | -8.89K | 4.60% |
Earnings per share | -0.61 | 39.60% |
EBITDA | -22.26M | 63.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 183.79M | -45.57% |
Total assets | 265.71M | -37.24% |
Total liabilities | 217.54M | -1.20% |
Total equity | 48.17M | — |
Shares outstanding | 59.78M | — |
Price to book | 1.70 | — |
Return on assets | -21.59% | — |
Return on capital | -56.42% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -36.65M | 39.62% |
Cash from operations | -34.82M | 27.47% |
Cash from investing | 18.00M | 222.49% |
Cash from financing | 420.00K | 4.48% |
Net change in cash | -16.40M | 73.67% |
Free cash flow | -13.92M | 50.66% |
About
Founded
1993
Website
Employees
149